INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $758,948 | -7.2% | 24,003 | +19.9% | 0.00% | 0.0% |
Q2 2023 | $817,639 | +2.9% | 20,025 | -6.2% | 0.00% | 0.0% |
Q1 2023 | $794,463 | +12.0% | 21,348 | +5.1% | 0.00% | 0.0% |
Q4 2022 | $709,487 | +67.7% | 20,314 | +167.6% | 0.00% | 0.0% |
Q3 2022 | $423,000 | +8.2% | 7,592 | +0.2% | 0.00% | 0.0% |
Q2 2022 | $391,000 | -52.7% | 7,577 | -12.4% | 0.00% | -50.0% |
Q1 2022 | $826,000 | -18.5% | 8,645 | +1.0% | 0.00% | 0.0% |
Q4 2021 | $1,013,000 | -8.0% | 8,557 | +4.4% | 0.00% | 0.0% |
Q3 2021 | $1,101,000 | -35.9% | 8,197 | -22.6% | 0.00% | -50.0% |
Q2 2021 | $1,717,000 | +80.0% | 10,586 | -11.0% | 0.00% | +100.0% |
Q1 2021 | $954,000 | +58.5% | 11,897 | +7.3% | 0.00% | 0.0% |
Q4 2020 | $602,000 | +215.2% | 11,087 | +15.2% | 0.00% | +100.0% |
Q3 2020 | $191,000 | -8.2% | 9,621 | -2.9% | 0.00% | 0.0% |
Q2 2020 | $208,000 | +23.8% | 9,912 | -26.8% | 0.00% | 0.0% |
Q1 2020 | $168,000 | – | 13,539 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |